Both Semaglutide and Mounjaro represent new approaches to addressing type 2 diabetes, and increasingly, weight management. Semaglutide is a twin agonist that targets several hormones involved in blood sugar control: https://thingstoknowabouttirzepa799628.digitollblog.com/profile